| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 37.782 | 50.747 | 58.510 | 77.160 | 91.543 | 125.661 | 138.771 | 167.386 |
| Total Income - EUR | - | - | 37.782 | 50.747 | 58.510 | 77.160 | 91.543 | 125.661 | 138.771 | 170.551 |
| Total Expenses - EUR | - | - | 16.434 | 16.995 | 22.153 | 18.203 | 19.845 | 23.715 | 26.304 | 24.198 |
| Gross Profit/Loss - EUR | - | - | 21.348 | 33.752 | 36.357 | 58.957 | 71.698 | 101.946 | 112.467 | 146.353 |
| Net Profit/Loss - EUR | - | - | 19.699 | 32.230 | 34.601 | 56.791 | 69.227 | 99.451 | 111.107 | 141.386 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bio-Ginecologie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 41.896 | 33.757 | 25.881 | 18.305 | 10.970 | 4.966 | 1.263 | 2.739 |
| Current Assets | - | - | 11.982 | 41.337 | 45.887 | 80.532 | 98.053 | 95.192 | 110.581 | 258.599 |
| Inventories | - | - | 284 | 0 | 0 | 0 | 0 | 0 | 748 | 0 |
| Receivables | - | - | 3.241 | 3.404 | 5.995 | 5.588 | 7.538 | 70.663 | 47.476 | 99.218 |
| Cash | - | - | 8.457 | 37.934 | 39.893 | 74.944 | 90.515 | 24.529 | 62.357 | 3.580 |
| Shareholders Funds | - | - | 19.743 | 51.610 | 53.606 | 86.748 | 103.514 | 99.500 | 111.156 | 141.434 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 34.136 | 23.484 | 18.162 | 12.088 | 5.509 | 658 | 688 | 119.904 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bio-Ginecologie Srl